An integrated platform of genomic assays reveals small-molecule bioactivities (original) (raw)

• Giaever, G. et al. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc. Natl. Acad. Sci. USA 101, 793–798 (2004).
  Article CAS Google Scholar
• Lum, P.Y. et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116, 121–137 (2004).
  Article CAS Google Scholar
• Lee, W. et al. Genome-wide requirements for resistance to functionally distinct DNA-damaging agents. PLoS Genet. 1, 235–246 (2005).
  Article CAS Google Scholar
• Parsons, A.B. et al. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126, 611–625 (2006).
  Article CAS Google Scholar
• Rine, J., Hansen, W., Hardeman, E. & Davis, R.W. Targeted selection of recombinant clones through gene dosage effects. Proc. Natl. Acad. Sci. USA 80, 6750–6754 (1983).
  Article CAS Google Scholar
• Luesch, H. et al. A genome-wide overexpression screen in yeast for small-molecule target identification. Chem. Biol. 12, 55–63 (2005).
  Article CAS Google Scholar
• Butcher, R.A. et al. Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway. Nat. Chem. Biol. 2, 103–109 (2006).
  Article CAS Google Scholar
• Parsons, A.B. et al. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 22, 62–69 (2004).
  Article CAS Google Scholar
• Hughes, T.R. et al. Functional discovery via a compendium of expression profiles. Cell 102, 109–126 (2000).
  Article CAS Google Scholar
• Kung, C. et al. Chemical genomic profiling to identify intracellular targets of a multiplex kinase inhibitor. Proc. Natl. Acad. Sci. USA 102, 3587–3592 (2005).
  Article CAS Google Scholar
• Lamb, J. et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929–1935 (2006).
  Article CAS Google Scholar
• Pierce, S.E. et al. A unique and universal molecular barcode array. Nat. Methods 3, 601–603 (2006).
  Article CAS Google Scholar
• Pierce, S.E., Davis, R.W., Nislow, C. & Giaever, G. Genome-wide analysis of barcoded Saccharomyces cerevisiae gene-deletion mutants in pooled cultures. Nat. Protoc. 2, 2958–2974 (2007).
  Article CAS Google Scholar
• Brenner, C. Chemical genomics in yeast. Genome Biol. 5, 240 (2004).
  Article Google Scholar
• Giaever, G. et al. Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat. Genet. 21, 278–283 (1999).
  Article CAS Google Scholar
• Li, X. et al. Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. Chem. Biol. 11, 1423–1430 (2004).
  Article CAS Google Scholar
• Breitling, R., Armengaud, P. & Amtmann, A. Vector analysis as a fast and easy method to compare gene expression responses between different experimental backgrounds. BMC Bioinformatics 6, 181 (2005).
  Article Google Scholar
• Myers, C.E., Lippman, M.E., Elliot, H.M. & Chabner, B.A. Competitive protein binding assay for methotrexate. Proc. Natl. Acad. Sci. USA 72, 3683–3686 (1975).
  Article CAS Google Scholar
• Kontoyiannis, D.P., Sagar, N. & Hirschi, K.D. Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae . Antimicrob. Agents Chemother. 43, 2798–2800 (1999).
  Article CAS Google Scholar
• Zheng, X.F., Florentino, D., Chen, J., Crabtree, G.R. & Schreiber, S.L. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell 82, 121–130 (1995).
  Article CAS Google Scholar
• Koltin, Y. et al. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein. Mol. Cell. Biol. 11, 1718–1723 (1991).
  Article CAS Google Scholar
• Honkanen, R.E. Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A. FEBS Lett. 330, 283–286 (1993).
  Article CAS Google Scholar
• Li, Y.M. & Casida, J.E. Cantharidin-binding protein: identification as protein phosphatase 2A. Proc. Natl. Acad. Sci. USA 89, 11867–11870 (1992).
  Article CAS Google Scholar
• Ishihara, H. et al. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem. Biophys. Res. Commun. 159, 871–877 (1989).
  Article CAS Google Scholar
• Fujiki, H. & Suganuma, M. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv. Cancer Res. 61, 143–194 (1993).
  Article CAS Google Scholar
• MacKintosh, C., Beattie, K.A., Klumpp, S., Cohen, P. & Codd, G.A. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett. 264, 187–192 (1990).
  Article CAS Google Scholar
• Walsh, E.P., Lamont, D.J., Beattie, K.A. & Stark, M.J. Novel interactions of Saccharomyces cerevisiae type 1 protein phosphatase identified by single-step affinity purification and mass spectrometry. Biochemistry 41, 2409–2420 (2002).
  Article CAS Google Scholar
• Krogan, N.J. et al. High-definition macromolecular composition of yeast RNA-processing complexes. Mol. Cell 13, 225–239 (2004).
  Article CAS Google Scholar
• Andrews, P.D. & Stark, M.J. Type 1 protein phosphatase is required for maintenance of cell wall integrity, morphogenesis and cell cycle progression in Saccharomyces cerevisiae . J. Cell Sci. 113, 507–520 (2000).
  CAS PubMed Google Scholar
• Baker, S.H., Frederick, D.L., Bloecher, A. & Tatchell, K. Alanine-scanning mutagenesis of protein phosphatase type 1 in the yeast Saccharomyces cerevisiae . Genetics 145, 615–626 (1997).
  CAS PubMed PubMed Central Google Scholar
• Hsu, J.Y. et al. Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 102, 279–291 (2000).
  Article CAS Google Scholar
• Bloecher, A. & Tatchell, K. Defects in Saccharomyces cerevisiae protein phosphatase type I activate the spindle/kinetochore checkpoint. Genes Dev. 13, 517–522 (1999).
  Article CAS Google Scholar
• Hillenmeyer, M.E. et al. The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 320, 362–365 (2008).
  Article CAS Google Scholar
• Martin, J.L. & McMillan, F.M. SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold. Curr. Opin. Struct. Biol. 12, 783–793 (2002).
  Article CAS Google Scholar
• Arnaud, M.B. et al. Sequence resources at the Candida Genome Database. Nucleic Acids Res. 35, D452–D456 (2007).
  Article CAS Google Scholar
• Bliss, C. The toxicity of poisons applied jointly. Ann. Appl. Biol. 26, 585–615 (1939).
  Article CAS Google Scholar
• Lehar, J. et al. Chemical combination effects predict connectivity in biological systems. Mol. Syst. Biol. 3, 80 (2007).
  Article Google Scholar
• Stark, C. et al. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 34, D535–D539 (2006).
  Article CAS Google Scholar
• Young, D.W. et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat. Chem. Biol. 4, 59–68 (2008).
  Article CAS Google Scholar
• Baguley, B.C. & Nash, R. Antitumour activity of substituted 9-anilinoacridines–comparison of in vivo and in vitro testing systems. Eur. J. Cancer 17, 671–679 (1981).
  Article CAS Google Scholar
• Nelson, E.M., Tewey, K.M. & Liu, L.F. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinylamino)-methanesulfon-m-anisidide. Proc. Natl. Acad. Sci. USA 81, 1361–1365 (1984).
  Article CAS Google Scholar
• Denny, W.A. et al. Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents. J. Med. Chem. 25, 276–315 (1982).
  Article CAS Google Scholar
• Terstappen, G.C., Schlupen, C., Raggiaschi, R. & Gaviraghi, G. Target deconvolution strategies in drug discovery. Nat. Rev. Drug Discov. 6, 891–903 (2007).
  Article CAS Google Scholar
• Zimmermann, G.R., Lehar, J. & Keith, C.T. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov. Today 12, 34–42 (2007).
  Article CAS Google Scholar
• Borisy, A.A. et al. Systematic discovery of multicomponent therapeutics. Proc. Natl. Acad. Sci. USA 100, 7977–7982 (2003).
  Article CAS Google Scholar
• Bishop, A.C. et al. A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407, 395–401 (2000).
  Article CAS Google Scholar
• Gietz, R.D., Schiestl, R.H., Willems, A.R. & Woods, R.A. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 11, 355–360 (1995).
  Article CAS Google Scholar
• Kadosh, D. & Johnson, A.D. Rfg1, a protein related to the Saccharomyces cerevisiae hypoxic regulator Rox1, controls filamentous growth and virulence in Candida albicans . Mol. Cell. Biol. 21, 2496–2505 (2001).
  Article CAS Google Scholar
• Lan, C.Y. et al. Metabolic specialization associated with phenotypic switching in Candida albicans . Proc. Natl. Acad. Sci. USA 99, 14907–14912 (2002).
  Article CAS Google Scholar
• Breitling, R., Armengaud, P., Amtmann, A. & Herzyk, P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 573, 83–92 (2004).
  Article CAS Google Scholar